Skip to main content
FinSpry Logo
FinSpry
ATRA logo
ATRA
(NASDAQ)
Atara Biotherapeutics, Inc.
$10.23-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Atara Biotherapeutics (ATRA) Stock Price & Financial Analysis

Atara Biotherapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$10.23 - $11.33
52-Week High$19.15
52-Week Low$3.92
Open$10.60
Volume106.57K
Average Volume (3M)52.04K
Market Cap137.43M
Shares Outstanding14.08M
Price to Sales (P/S)5.94
Price to Book (P/B)-3.68
EV/EBITDA-25.39
Revenue (TTM)23.14M
Net Income (TTM)-9.47M
Free Cash Flow (TTM)-26.22M
EPS (TTM)$-0.72
Profit Margin-40.91%
Operating Margin-24.76%
50-Day MA$9.11
200-Day MA$8.80
52-Week Change-16.01%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Atara Biotherapeutics

What is the current stock price for ATRA?

As of the latest trading session, ATRA stock trades at $10.23. The 52-week range is $3.92–$19.15, with a day range of $10.23–$11.33.

What is the P/E ratio for ATRA?

The P/E ratio (Price-to-Earnings) for ATRA is shown in the Key Statistics section. This valuation metric helps compare Atara Biotherapeutics, Inc. to industry peers.

Does ATRA pay dividends?

Atara Biotherapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ATRA?

Based on 2 analysts, the consensus for ATRA is Buy.

What is the market cap of ATRA?

Atara Biotherapeutics's market capitalization is $144.0M, classifying it as a micro-cap company. Atara Biotherapeutics operates in the Healthcare sector within the Biotechnology industry.